Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Alison

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Palliative Medicine|January 1, 1994
Resuscitation and non-resuscitation ordersD L Alison, F Hicks
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 15, 2000
Palliative care activity in a medical oncology unit: the implications for oncology trainingM T Kiely, D L Alison
Palliative Medicine|January 1, 1996
Questions of training--choice or force?M I Bennett, D L Alison, W M O'Neill, et al.
Cancer Research|June 1, 1986
Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studiesA L Jackman, D L Alison, A H Calvert, et al.
Clinical Radiology|October 18, 2002
Cerebral metastasis and other cerebral events in women with ovarian cancerA Sanderson, S C Bonington, B M Carrington, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717)D L Alison, D R Newell, C Sessa, et al.
Cancer Treatment Reports|August 1, 1986
Pharmacokinetics of the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB3717) in the mouseD R Newell, D L Alison, A H Calvert, et al.
The Journal of Pathology|September 1, 1986
Cluster differentiation antigen expression, proliferative activity and clinical stage in centroblastic centrocytic lymphomasJ M Williamson, I Grigor, M E Smith, et al.
Hematological Oncology|January 1, 1994
Prognosis in low grade non-Hodgkin's lymphoma: relevance of the number of sites involved, absolute lymphocyte count and serum immunoglobulin levelD Parker, D L Alison, D L Barnard, et al.
Histopathology|October 1, 1987
Ploidy, proliferative activity, cluster differentiation antigen expression and clinical remission in high-grade non-Hodgkin's lymphomaJ M Williamson, I Grigor, M E Smith, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Palliative Medicine|January 1, 1994
Resuscitation and non-resuscitation ordersD L Alison, F Hicks
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 15, 2000
Palliative care activity in a medical oncology unit: the implications for oncology trainingM T Kiely, D L Alison
Palliative Medicine|January 1, 1996
Questions of training--choice or force?M I Bennett, D L Alison, W M O'Neill, et al.
Cancer Research|June 1, 1986
Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studiesA L Jackman, D L Alison, A H Calvert, et al.
Clinical Radiology|October 18, 2002
Cerebral metastasis and other cerebral events in women with ovarian cancerA Sanderson, S C Bonington, B M Carrington, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717)D L Alison, D R Newell, C Sessa, et al.
Cancer Treatment Reports|August 1, 1986
Pharmacokinetics of the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB3717) in the mouseD R Newell, D L Alison, A H Calvert, et al.
The Journal of Pathology|September 1, 1986
Cluster differentiation antigen expression, proliferative activity and clinical stage in centroblastic centrocytic lymphomasJ M Williamson, I Grigor, M E Smith, et al.
Hematological Oncology|January 1, 1994
Prognosis in low grade non-Hodgkin's lymphoma: relevance of the number of sites involved, absolute lymphocyte count and serum immunoglobulin levelD Parker, D L Alison, D L Barnard, et al.
Histopathology|October 1, 1987
Ploidy, proliferative activity, cluster differentiation antigen expression and clinical remission in high-grade non-Hodgkin's lymphomaJ M Williamson, I Grigor, M E Smith, et al.
Pageof 2